Selventa
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Selventa
The Trouble With Options
A panel of experts at BIO 2012 concludes that option-based deals are useful, but limited as a vehicle for an alternate source of non-dilutive financing for biotechs because they throw more risk on licensees with early-stage assets.
Company Information
- Industry
- Digital Health
- Services
-
Services
- Consulting Services
- Other Names / Subsidiaries
-
- Genstruct, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice